STK32C Activated IL-6/JAK2/STAT3 Signaling and Promoted Tumor Angiogenesis

0
28
STK32C acted as a pro-angiogenic driver in colorectal cancer by activating IL-6/JAK2/STAT3 signaling via STAT3 Thr196 phosphorylation.
[British Journal of Cancer]
Abstract